News from astellas pharma inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Aug 31, 2015, 00:27 ET
Astellas Pharma Europe Logo

Über 550 Frauen, deren Leben durch "Action on Fistula" transformiert wurde

- Bahnbrechende Kampagne beendet die 51-jährige Wartezeit einer Frau für...

Aug 30, 2015, 09:11 ET
Astellas Pharma Europe Logo

Más de 550 mujeres mejoran su vida gracias a Action on Fistula

  - La revolucionaria campaña pone fin a los 51 años de espera de una mujer por el tratamiento quirúrgico - Las...

Aug 30, 2015, 09:09 ET
Astellas Pharma Europe Logo

Le programme Action on Fistula a déjà transformé la vie de plus de 550 femmes

  - Une campagne révolutionnaire met fin aux 51 années d'attente d'une patiente pour un traitement...

Aug 05, 2015, 09:00 ET
Australian rugby player Nick Cummins (left) promotes the #pass4prostate challenge

#pass4prostate Challenge Raises Prostate Cancer Awareness and Research Funds

 Seeking to support men and their loved ones facing the challenges that come with a diagnosis of prostate cancer, USA Rugby, the Australian...

Jun 01, 2015, 17:00 ET
Astellas is a pharmaceutical company dedicated to improving the health of people around the world.

New Enzalutamide Data In Triple-negative Breast Cancer Presented At The 2015 American Society Of Clinical Oncology Annual Meeting

 Astellas Pharma Inc. (Tokyo: 4503) announced that data from a Phase 2 study evaluating the investigational use of enzalutamide as a single...

May 30, 2015, 15:07 ET
Astellas is a pharmaceutical company dedicated to improving the health of people around the world.

Astellas Announces Preliminary Phase 1/2 Safety, Tolerability And Efficacy Data For ASP2215 In Patients With Relapsed Or Refractory Acute Myeloid Leukemia (AML)

 Astellas Pharma Inc. (TSE: 4503) today announced that preliminary data from a Phase 1/2 trial on the safety, tolerability and efficacy of...

May 26, 2015, 05:26 ET
Astellas Pharma

Astellas Pharma EMEA Celebrates Its 10th Anniversary

For the Last Decade Astellas Has Been Enhancing Patient Care & Quality of Life Throughout Europe, the Middle East and...

May 17, 2015, 12:52 ET
Astellas Pharma Inc. logo

Mirabegron As Add-On Treatment To Solifenacin Therapy Demonstrated Superior Results To Solifenacin Monotherapy In BESIDE Trial

 Astellas Pharma Inc. (TSE: 4503) announced today that results from its Phase 3b BESIDE clinical trial demonstrated solifenacin (SOLI) with...

May 17, 2015, 12:48 ET
Astellas is a pharmaceutical company dedicated to improving the health of people around the world

Astellas And Medivation Announce New Enzalutamide Data Presented At The 2015 American Urological Association Annual Meeting

 Astellas Pharma Inc (TSE:4503) and Medivation, Inc (NASDAQ: MDVN) today announced data from the Phase 2 STRIVE trial comparing...

Apr 21, 2015, 19:30 ET
Astellas is a pharmaceutical company dedicated to improving the health of people around the world.

Astellas Pharma And Potenza Therapeutics Partner To Build A Portfolio Of Immuno-Oncology Therapeutics

 Astellas Pharma Inc. (Tokyo: 4503) and Potenza Therapeutics, Inc., a biotechnology company developing a portfolio of immuno-oncology programs,...

Apr 16, 2015, 08:00 ET

Health Canada Approves New Indication for the Use of Xtandi® (enzalutamide) Capsules for Patients with Metastatic Castration-Resistant Prostate Cancer

Approval based on improved overall survival, delayed time to radiographic progression and an overall positive risk-benefit profile MARKHAM, ON,...

Apr 06, 2015, 09:00 ET
Astellas is a pharmaceutical company dedicated to improving the health of people around the world.

Astellas Appoints Shontelle Dodson to Lead Medical Excellence Function

 Astellas ("Astellas,") (Tokyo: 4503) today announced that Dr. Shontelle Dodson has been named vice president, Medical Excellence, Medical...

Apr 03, 2015, 09:00 ET
Astellas is a pharmaceutical company dedicated to improving the health of people around the world.

MD Anderson, Astellas Pharma Sign Option Agreement for Monoclonal Antibody Drug Targeting Acute Myeloid Leukemia

Astellas Pharma Inc. (TSE: 4503) and The University of Texas MD Anderson Cancer Center today announced the signing of an option agreement to...

Apr 02, 2015, 07:00 ET
Astellas is a pharmaceutical company dedicated to improving the health of people around the world.

Enzalutamide Demonstrates Statistically Significant Improvement In Progression Free Survival Compared With Bicalutamide In Strive Trial

 Astellas Pharma Inc. (TSE: 4503) and Medivation, Inc. (NASDAQ: MDVN) today announced topline results from the Phase 2 STRIVE trial...

Apr 01, 2015, 14:04 ET
Astellas is a pharmaceutical company dedicated to improving the health of people around the world.

Astellas Teams Up with The Chris Klug Foundation on the Bounce Back Award to Recognize Extraordinary Transplant Recipients

 Astellas Pharma US, Inc., in partnership with the Chris Klug Foundation (CKF), is pleased to sponsor the second annual Bounce Back Award....

Mar 24, 2015, 07:00 ET
Astellas is a pharmaceutical company dedicated to improving the health of people around the world.

Astellas and Medivation Announce New Enzalutamide Data Presented During Plenary Presentations at the 2015 European Association of Urology Congress

 Astellas Pharma Inc. (Tokyo: 4503) and Medivation, Inc. (Nasdaq: MDVN) today announced new data from the Phase 2 TERRAIN trial of enzalutamide...

Mar 16, 2015, 16:10 ET
Astellas is a pharmaceutical company dedicated to improving the health of people around the world.

New Enzalutamide Data To Be Presented In Late Breaking News Plenary Session At European Association Of Urology Congress

Astellas Pharma US, Inc., a U.S. subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503) and Medivation, Inc. (Nasdaq: MDVN) announced that...

Feb 24, 2015, 07:20 ET

El estudio DIAMOND proporciona visión sobre función renal y profilaxis de rechazo de órganos

- El estudio DIAMOND (ADVAGRAF Studied in Combination With Mycophenolate Mofetil (MMF) and Basiliximabin Liver Transplantation) proporciona...